Non-hematological role of erythropoietin;Pozahematologiczna rola erytropetyny

Onkologia Polska

Volumn 6, Issue 3, 2003, Pages 109-112

  Duchnowska, Renata ^a   Szczylik, Cezary ^a  

^a II Katedry Pediatrii   (Poland)

Author keywords

Epo; EpoR; Erythropoietin

Indexed keywords

ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR;

ARTICLE; BONE MARROW; BRAIN ISCHEMIA; CANCER; CELL PROTECTION; CENTRAL NERVOUS SYSTEM; ENDOCRINE SYSTEM; ENDOTHELIUM CELL; EPITHELIUM CELL; HUMAN; HYPOXIA; INTRACELLULAR FLUID; KIDNEY; LACTATION; MAMMARY GLAND; MILK; OVIDUCT; PARACRINE SIGNALING; PLACENTA; PROTEIN EXPRESSION; PROTEIN FUNCTION; UTERUS;

EID: 0347134413     PISSN: 15056732     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Eckardt K.U.: Erythropoietin production in liver and kidneys. Curr. Opin. Nephrol. Hypertens. 1996, 5, 28-34.
2. Krantz S.B.: Erythropoietin. Blood 1991, 77, 419-434.
3. Gaciong Z.: Erytropoetyna. [w:] Cytokiny. Zastosowanie kliniczne. Jedrzejczak W., Podolak-Dawidziak M. (red.). Volumed s.c., Wrocław, 1997, 53-63.
4. Jacobson L.O., Goldwasser E.: The role of the kidney in erythropoiesis. Nature 1957, 179, 633-634.
5. Tan C.C., Eckardt K.U., Firth J.D. i wsp.: Feedback modulation of renal and hepatic erythropoietin mRNA in response to graded anemia and hypoxia. Am. J. Physiol. 1992, 263, 474-481.
6. Bunn H.F., Gu J., Huang L.E. i wsp.: Erythropoietin: a model system for studying oxygen - dependent gene regulation. J. Exp. Biol. 1998, 201, 1197-1201.
7. Zhang W., Tsuchiya T., Yasukochi Y. i wsp.: Transitional change in interaction between HIF-1 and INF-4 in response to hypoxia. J. Hum. Genet. 1999, 44, 293-299.
8. Silva M., Grillot D., Benito A. i wsp.: Erythropoietin can promote erythroid progenitor survival by repressing apoptosis through Bcl-XL and Bcl-2. Blood 1996, 88, 1576-1582.
9. Silva M., Benito A., Sanz C. i wsp.: Erythropoietin can reduce the expression of bcl-x (L) through Stat 5 in erythropoietin-dependent progenitor cell lines. J. Biol. Chem. 1999, 274, 22165-22169.
10. Sasaki R., Masuda S., Nagao M.: Pleiotropic functions and tissue-specific expression of erythropoietin. New Physiol. Sci. 2001, 16, 110-113.
11. Sasaki R., Masuda S., Nagao M. i wsp.: Erythropoietin: multiple physiological functions and regulation of biosynthesis. Biosci. Biotechnol. Biochem. 2000, 64, 1775-1793.
12. Kling P.J., Sullivan T.M., Roberts R.A. i wsp.: Human milk as a potential enteral source of erythropoietin. Pediatr. Res. 1998, 43, 216-221.
13. Juul S.E., Zhao Y., Dame J.B. i wsp.: Orgin and fate of erythropoietin in human milk. Pediatr. Res. 2000, 48, 660-667.
14. Juul S.E., Joyce A.E., Zhao Y. i wsp.: Why is erythropoietin present in human milk? Studies of erythropoietin receptors on enterocytes of human and rat neonates. Pediatr. Res. 1999, 46, 263-268.
15. Chikuma M., Masuda S., Kobayashi T. i wsp.: Tissue-specific regulation of erythropoietin production in the murine kidney, brain, and uterus. Am. J. Physiol. Endocrinol. Metab. 2000, 279, 1242-1248.
16. Siebenlist U.: Signal transduction. Barriers come down. Nature 2001, 412, 601-602.
17. Sakanaka M., Wen T.C., Masuda S. i wsp.: In vivo evidence that erythropoietin protects neurons from ischemic damage. Proc. Natl. Acad. Sci. USA 1998, 95, 4635-4640.
18. Marti H.H., Wenger R.H., Rivas L.A. i wsp.: Erythropoietin gene expression in human, monkey and murine brain. Eur. J. Neurosci. 1996, 8, 666-676.
19. Brines M.L., Ghezzi P., Keenan S. i wsp.: Erythropoietin crosses the blood - brain barrier to protect against experimental injury. Proc. Natl. Acad. Sci. USA 2000, 97, 10526-10531.
20. Bernaudin M., Marti H.H., Roussel S. i wsp.: A potential role for erythropoietin in focal permanent cerebral ischemia in mice. J. Cereb. Blood Flow Metab. 1999, 19, 643-651.
21. Digicaylioglu M., Lipton S.A.: Erythropoietin-mediated neuroprotection involves cross-talk between JAK2 and NF-kB signaling cascades. Nature 2001, 412, 641-647.
22. Yasuda Y., Masuda S., Chikuma M. i wsp.: Estrogen-dependent production of erythropoietin in uterus and its implication in uterine angiogenesis. J. Biol. Chem. 1998, 273, 25381-25387.
23. Masuda S., Kobayashi T., Chikuma M. i wsp.: The oviduct produces erythropoietin in an estrogen- and oxygen-dependent manner. Am. J. Physiol. Endocrinol. Metab. 2000, 278, 1038-1044.
24. Yokomizo R., Matsuzaki S., Uehara S. i wsp.: Erythropoietin and erythropoietin receptor expression in human endometrium throughout the menstrual cycle. Mol. Hum. Reprod. 2002, 8, 441-446.
25. Mukundan H., Resta T.C., Kanagy N.L.: 17-beta estradiol decreases hypoxic induction of erythropoietin gene expression. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2002, 283, 496-504.
26. Conrad K.P., Benyo D.F., Westerhausen-Larsen A. i wsp.: Expresssion of erythropoietin by the human placenta. FASEB J. 1996, 10, 760-768.
27. Anagnostou A., Lee E.S., Kessimian N. i wsp.: Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells. Proc. Natl. Acad. Sci. USA 1990, 87, 5978-5982.
28. Anagnostou A., Liu Z., Steiner M. i wsp.: Erythropoeitin receptor mRNA expression in human endothelial cells. Proc. Natl. Acad. Sci. USA 1994, 91, 3974-3978.
29. Acs G., Zhang P.J., Rebbeck T.R. i wsp.: Immunohistochemical expression of erythropoietin and erythropoietin receptor in breast carcinoma. Cancer 2002, 95, 969-981.
30. Westenfelder C., Baranowki R.L.: Erythropoietin stimulates proliferation of human renal crcinoma cells. Kidney Int. 2000, 58, 647-657.
31. Acs G., Acs P., Beckwith S.M. i wsp.: Erythropoietin and erythropoietin receptor expression in human cancer. Cancer Res. 2001, 61, 3561-3565.